Cargando…
Ethics of iPSC-Based Clinical Research for Age-Related Macular Degeneration: Patient-Centered Risk-Benefit Analysis
The opportunity to undergo an induced pluripotent stem cell-based autologous transplant can strike patients as a chance for a cure from a debilitating condition with few options for respite. However, when clinical studies of this caliber present themselves, patients and researchers, each with their...
Autores principales: | Nakano-Okuno, Mariko, Borah, B. Rashmi, Nakano, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225048/ https://www.ncbi.nlm.nih.gov/pubmed/24974102 http://dx.doi.org/10.1007/s12015-014-9536-x |
Ejemplares similares
-
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model
por: Sharma, Ruchi, et al.
Publicado: (2021) -
Human iPSC- and Primary-Retinal Pigment Epithelial Cells for Modeling Age-Related Macular Degeneration
por: Fisher, Cody R., et al.
Publicado: (2022) -
Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration
por: Ebeling, Mara C., et al.
Publicado: (2022) -
The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research
por: Patel, Leena, et al.
Publicado: (2023) -
iPSC-based treatment of age-related macular degeneration (AMD): The path to success requires more than blind faith
por: Li, Fei, et al.
Publicado: (2017)